BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2782915)

  • 1. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl Tn antigen: (1). Evaluation of assay conditions and normal values. STN Study Group].
    Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3213-9. PubMed ID: 2782915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--1. Evaluation of assay conditions and normal values].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2195-202. PubMed ID: 2660748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance of serum sialyl Tn antigen in patients with gynecological cancer. STN Study Group].
    Noda K; Shiota M; Tanizawa O; Inoue M; Tenjin Y; Sugishita T; Yakushiji M; Miyoshi T; Nozawa S; Sakuma T
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1287-96. PubMed ID: 2069400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for 2----6 sialyl Lewis a antigen--2. Evaluation of clinical significance].
    Imura H; Takahashi T; Matsuda T; Yoshida O; Ohkura H; Seitetsu Y; Seino Y; Ishii M; Kuwabara M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2203-12. PubMed ID: 2660749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Initial basic and clinical evaluation of a solid-phase immunoradiometric assay for sialyl SSEA-1 antigen: 1. Evaluation of assay conditions and normal values].
    Imura H; Endo J; Ohkura H; Ishii M; Ariyoshi Y; Abe O; Masamune O; Nishimoto Y; Fukushi Y; Orikasa S
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1315-21. PubMed ID: 2883936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Basic and clinical evaluation of an immunoradiometric competitive inhibition assay for sialyl TN antigen: (2). Evaluation of clinical significance. STN Study Group].
    Imura H; Mori T; Ohkura H; Ishii M; Ariyoshi H; Endo J; Kitao M; Takeda I; Kobayashi H; Inoue M
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3221-30. PubMed ID: 2571323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical significance of serum sialyl Tn antigen levels in patients with gynecologic tumors].
    Shimizu C; Inoue M; Ogawa H; Ueda G; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1537-42. PubMed ID: 2273309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
    Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
    Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
    [No Abstract]   [Full Text] [Related]  

  • 11. Basic evaluation of an immunoradiometric competitive inhibition assay for sialosyl-Tn antigen in sera in women. Assay conditions and normal values.
    Ryuko K; Iwanari O; Nakayama S; Kitao M; Karino K; Endo J
    Cancer; 1992 May; 69(9):2361-7. PubMed ID: 1562984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients.
    Nakagoe T; Fukushima K; Tanaka K; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
    J Exp Clin Cancer Res; 2002 Mar; 21(1):107-13. PubMed ID: 12071515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H
    Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialyl Lewis-Xi antigen in patients with gynecologic tumors.
    Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O
    Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer.
    Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I
    Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [STN (sialyl Tn antigen)].
    Kannagi R
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():659-62. PubMed ID: 16149605
    [No Abstract]   [Full Text] [Related]  

  • 17. [Basic and clinical evaluation of measurement of pancreatic cancer associated antigen, SPan-1].
    Chung YS; Nakata B; Tanaka H; Kubo T; Satake K; Sowa M; Umeyama K
    Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):228-33. PubMed ID: 2325607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer.
    Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K
    Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
    Ohuchi N; Takahashi K; Matoba N; Mori S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers].
    Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hasimoto M
    Gan To Kagaku Ryoho; 1992 Jun; 19(6):827-35. PubMed ID: 1605661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.